Cargando…

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China

This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Tao-Hsin, Lin, Xiao-Qing, Chen, Yan, Zhang, Mei-Xian, Zhu, Jian-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746460/
https://www.ncbi.nlm.nih.gov/pubmed/35880816
http://dx.doi.org/10.1080/21645515.2022.2099210
_version_ 1784849365341306880
author Tung, Tao-Hsin
Lin, Xiao-Qing
Chen, Yan
Zhang, Mei-Xian
Zhu, Jian-Sheng
author_facet Tung, Tao-Hsin
Lin, Xiao-Qing
Chen, Yan
Zhang, Mei-Xian
Zhu, Jian-Sheng
author_sort Tung, Tao-Hsin
collection PubMed
description This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants received ane-mail or e-poster on WeChat. A total of 1576 subjects participated the survey. A total of 66.4% (1046/1576) of the respondents were willing to pay for a booster dose of COVID-19 vaccine for themselves. Using binary logistic regression analysis, the following factors were significantly related to a WTP for a booster dose of COVID-19 vaccine: 1) confidence in the safety of the COVID-19 vaccines (high vs. low, OR: 4.30, 95%CI: 1.61–11.43), 2) confidence in the preventive effectiveness of the COVID-19 vaccines against SARS-CoV-2 virus (moderate vs. little, OR: 1.76, 95%CI: 1.30–2.38; great vs. little, OR: 2.244, 95%CI: 1.62–3.12), and 3) COVID-19 vaccine hesitancy (unhesitant vs. very unhesitant, OR: 0.67, 95%CI: 0.45–1.02; hesitant vs. very unhesitant, OR: 0.29, 95%CI: 0.19–0.44; very hesitant vs. very unhesitant, OR: 0.09, 95%CI: 0.03–0.27). This study revealed that a moderate proportion of participants responded that they would be willing to pay for a booster dose of COVID-19 vaccine. These findings suggest the importance of a detailed assessment and a health education plan that better understands the population’s risk perception as well as the potential health risks in China.
format Online
Article
Text
id pubmed-9746460
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97464602022-12-14 Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China Tung, Tao-Hsin Lin, Xiao-Qing Chen, Yan Zhang, Mei-Xian Zhu, Jian-Sheng Hum Vaccin Immunother Coronavirus – Research Paper This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants received ane-mail or e-poster on WeChat. A total of 1576 subjects participated the survey. A total of 66.4% (1046/1576) of the respondents were willing to pay for a booster dose of COVID-19 vaccine for themselves. Using binary logistic regression analysis, the following factors were significantly related to a WTP for a booster dose of COVID-19 vaccine: 1) confidence in the safety of the COVID-19 vaccines (high vs. low, OR: 4.30, 95%CI: 1.61–11.43), 2) confidence in the preventive effectiveness of the COVID-19 vaccines against SARS-CoV-2 virus (moderate vs. little, OR: 1.76, 95%CI: 1.30–2.38; great vs. little, OR: 2.244, 95%CI: 1.62–3.12), and 3) COVID-19 vaccine hesitancy (unhesitant vs. very unhesitant, OR: 0.67, 95%CI: 0.45–1.02; hesitant vs. very unhesitant, OR: 0.29, 95%CI: 0.19–0.44; very hesitant vs. very unhesitant, OR: 0.09, 95%CI: 0.03–0.27). This study revealed that a moderate proportion of participants responded that they would be willing to pay for a booster dose of COVID-19 vaccine. These findings suggest the importance of a detailed assessment and a health education plan that better understands the population’s risk perception as well as the potential health risks in China. Taylor & Francis 2022-07-26 /pmc/articles/PMC9746460/ /pubmed/35880816 http://dx.doi.org/10.1080/21645515.2022.2099210 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Research Paper
Tung, Tao-Hsin
Lin, Xiao-Qing
Chen, Yan
Zhang, Mei-Xian
Zhu, Jian-Sheng
Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title_full Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title_fullStr Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title_full_unstemmed Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title_short Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
title_sort willingness-to-pay for a booster dose of inactivated sars-cov-2 vaccine in taizhou, china
topic Coronavirus – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746460/
https://www.ncbi.nlm.nih.gov/pubmed/35880816
http://dx.doi.org/10.1080/21645515.2022.2099210
work_keys_str_mv AT tungtaohsin willingnesstopayforaboosterdoseofinactivatedsarscov2vaccineintaizhouchina
AT linxiaoqing willingnesstopayforaboosterdoseofinactivatedsarscov2vaccineintaizhouchina
AT chenyan willingnesstopayforaboosterdoseofinactivatedsarscov2vaccineintaizhouchina
AT zhangmeixian willingnesstopayforaboosterdoseofinactivatedsarscov2vaccineintaizhouchina
AT zhujiansheng willingnesstopayforaboosterdoseofinactivatedsarscov2vaccineintaizhouchina